94 related articles for article (PubMed ID: 7996473)
1. Characterization of PD 121981- and CGP 42112-induced unmasking of low concentration effects of angiotensin II in rabbit abdominal aorta.
Hong KW; Rhim BY; Shin YW; Yoo SE
J Pharmacol Exp Ther; 1994 Dec; 271(3):1591-6. PubMed ID: 7996473
[TBL] [Abstract][Full Text] [Related]
2. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.
Scott AL; Chang RS; Lotti VJ; Siegl PK
J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398
[TBL] [Abstract][Full Text] [Related]
3. Characterization of renal angiotensin II receptors using subtype selective antagonists.
Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
[TBL] [Abstract][Full Text] [Related]
4. Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.
Zwart AS; Davis EA; Widdop RE
Br J Pharmacol; 1998 Dec; 125(7):1429-36. PubMed ID: 9884070
[TBL] [Abstract][Full Text] [Related]
5. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
Cobb CS; Brown JA
Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
Chiu AT; Roscoe WA; McCall DE; Timmermans PB
Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
[TBL] [Abstract][Full Text] [Related]
8. Characterization of angiotensin receptors mediating the neuromodulatory effects of angiotensin in the vas deferens of the rabbit.
Hegde SS; Clarke DE
J Pharmacol Exp Ther; 1993 May; 265(2):601-8. PubMed ID: 8496811
[TBL] [Abstract][Full Text] [Related]
9. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
[TBL] [Abstract][Full Text] [Related]
10. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
[TBL] [Abstract][Full Text] [Related]
11. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
le Tran Y; Forster C
Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
[TBL] [Abstract][Full Text] [Related]
14. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
15. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.
Macari D; Whitebread S; Cumin F; De Gasparo M; Levens N
Eur J Pharmacol; 1994 Jun; 259(1):27-36. PubMed ID: 7957590
[TBL] [Abstract][Full Text] [Related]
16. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
Dubey RK; Flammer J; Lüscher TF
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2067-75. PubMed ID: 9761285
[TBL] [Abstract][Full Text] [Related]
18. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides.
Feuillan PP; Millan MA; Aguilera G
Regul Pept; 1993 Mar; 44(2):159-69. PubMed ID: 8469771
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin II subtype 2 (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte.
Rabkin SW
Can J Physiol Pharmacol; 1996 Feb; 74(2):125-31. PubMed ID: 8723023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
